Helping You Build Wealth With Honest Research
Since 1996. Try Now

MEMBER'S LOGINX

     
Invalid Username / Password
   
     
   
     
 
Invalid Captcha
   
 
 
 
(Please do not use this option on a public machine)
 
     
 
 
 
  Sign Up | Forgot Password?  

ORCHID PHARMA vs MYLAN (US) - Comparison Results

MYLAN (US)
   Change

Mylan is one of the world’s leading generics and specialty pharmaceutical company. Its products span to customers in about 140 countries across the world. The company maintains one of the industry’s broadest and highest quality product portfolios, wh... More

DO YOU LIKE THESE REPORTS? TELL US!

Financials

 ORCHID PHARMA   MYLAN
EQUITY SHARE DATA
    ORCHID PHARMA
Mar-23
MYLAN
Dec-18
ORCHID PHARMA/
MYLAN
5-Yr Chart
Click to enlarge
High Rs4393,967-   
Low Rs2732,184-   
Sales per share (Unadj.) Rs163.11,825.4-  
Earnings per share (Unadj.) Rs13.549.6-  
Cash flow per share (Unadj.) Rs27.0391.3-  
Dividends per share (Unadj.) Rs00-  
Avg Dividend yield %00-  
Book value per share (Unadj.) Rs168.71,974.7-  
Shares outstanding (eoy) m40.82514.50-   
Bonus / Rights / Conversions 00-  
Price / Sales ratio x2.21.7 129.5%   
Avg P/E ratio x26.362.0 42.4%  
P/CF ratio (eoy) x13.27.9 168.0%  
Price / Book Value ratio x2.11.6 135.4%  
Dividend payout %00-   
Avg Mkt Cap Rs m14,5221,582,214 0.9%   
No. of employees `000NA35.0 0.0%   
Total wages/salary Rs m6540-   
Avg. sales/employee Rs Th026,833.1-  
Avg. wages/employee Rs Th00-  
Avg. net profit/employee Rs Th0728.6-  
INCOME DATA
Net Sales Rs m6,659939,158 0.7%  
Other income Rs m1940-   
Total revenues Rs m6,853939,158 0.7%   
Gross profit Rs m1,235243,019 0.5%  
Depreciation Rs m548175,847 0.3%   
Interest Rs m32945,170 0.7%   
Profit before tax Rs m55222,002 2.5%   
Minority Interest Rs m00-   
Prior Period Items Rs m00-   
Extraordinary Inc (Exp) Rs m00-   
Tax Rs m0-3,500 -0.0%   
Profit after tax Rs m55225,502 2.2%  
Gross profit margin %18.525.9 71.7%  
Effective tax rate %0-15.9 -0.0%   
Net profit margin %8.32.7 305.5%  
BALANCE SHEET DATA
Current assets Rs m5,010524,425 1.0%   
Current liabilities Rs m3,719382,364 1.0%   
Net working cap to sales %19.415.1 128.2%  
Current ratio x1.31.4 98.2%  
Inventory Days Days5784 68.6%  
Debtors Days Days1,18093 1,264.0%  
Net fixed assets Rs m7,242182,181 4.0%   
Share capital Rs m408500 81.6%   
"Free" reserves Rs m6,4780-   
Net worth Rs m6,8861,015,998 0.7%   
Long term debt Rs m1,4881,096,588 0.1%   
Total assets Rs m12,2522,725,301 0.4%  
Interest coverage x2.71.5 180.2%   
Debt to equity ratio x0.21.1 20.0%  
Sales to assets ratio x0.50.3 157.7%   
Return on assets %7.22.6 277.4%  
Return on equity %8.02.5 319.6%  
Return on capital %10.53.2 331.0%  
Exports to sales %81.90-   
Imports to sales %37.60-   
Net fx Rs m2,7260-   
CASH FLOW
From Operations Rs m183195,157 0.1%  
From Investments Rs m-312-100,875 0.3%  
From Financial Activity Rs m312-90,916 -0.3%  
Net Cashflow Rs m1831,617 11.3%  
NM: Not Meaningful
Source: Company Annual Reports, Regulatory Filings, Equitymaster
The reporting currency for MYLAN (US) is United States Dollars. All data has been converted at 83.34 Rs / USD

Compare ORCHID PHARMA With: ACTAVIS (US)  ADCOCK INGRAM (S. Africa)  TEVA PHARMA (Israel)  

Compare ORCHID PHARMA With: BLISS GVS PHARMA  ZENITH DRUGS LTD.  ZENOTECH LABS  AMBALAL SARABHAI  DIVIS LABORATORIES  



Today's Market

Sensex Today Rallies 639 Points | Suzlon Energy Surges 5%, Grasim Industries 4% | 3 Reasons Why Indian Share Market is Rising Sensex Today Rallies 639 Points | Suzlon Energy Surges 5%, Grasim Industries 4% | 3 Reasons Why Indian Share Market is Rising(Closing)

After opening the day on positive note, Indian share markets gained the momentum as the session progressed and ended on firm footing.